A detailed history of Syon Capital LLC transactions in Dexcom Inc stock. As of the latest transaction made, Syon Capital LLC holds 3,283 shares of DXCM stock, worth $264,511. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,283
Previous 4,888 32.84%
Holding current value
$264,511
Previous $554 Million 60.29%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $102,720 - $186,276
-1,605 Reduced 32.84%
3,283 $220 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $12,354 - $15,730
112 Added 2.35%
4,888 $554 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $25,927 - $31,802
227 Added 4.99%
4,776 $662 Million
Q4 2023

Feb 02, 2024

BUY
$75.49 - $124.16 $30,271 - $49,788
401 Added 9.67%
4,549 $564 Million
Q3 2023

Nov 03, 2023

BUY
$86.06 - $137.93 $356,976 - $572,133
4,148 New
4,148 $387 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.